This presentation will cover the exciting new project designed for the Roche Cell & Gene Therapy network. The Genentech Cell Therapy project for a new state of the art production suites was recently completed and designed to be a flexible and future proof cGMP facility that allows for multiple product development and manufacturing. The facility design and engineering includes infrastructure & utility systems that will allow for multiple product types including cell therapies. The new facility is also organized to support products across all stages of development including, analytical development, manufacturing science & technology (MSAT) development, and clinical manufacturing. The new facility has been mastered planned with the ability to grow as needed to support future products such as medias, plasmids production, and related genomics products by building out internal shelled spaces and to grow its footprint while maintaining a fully functional and operating facility. Some products that the facility is designed to house are Plasmids, RNA, DNA, T-cell, and HESC's. The Cell Therapy project finished construction in June 2023 to support Start-up Operations from July to October 2023.